| Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study (NCT06964425) | University Hospital Olomouc | 2023-02-04 |
| Recurrence After Whipple's (RAW) Study (NCT04596865) | University Hospital Plymouth NHS Trust | 2020-10-12 |
| EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice (NCT03494023) | Clinical Hospital Colentina | 2018-03-27 |
| Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma (NCT03768375) | Shanghai Jiao Tong University School of Medicine | 2016-11-01 |
| Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma (NCT02836847) | Shanghai Jiao Tong University School of Medicine | 2016-07-01 |
| Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma (NCT03772132) | Shanghai Jiao Tong University School of Medicine | 2016-07-01 |
| Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer (NCT02238613) | 307 Hospital of PLA | 2014-08-01 |
| Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma (NCT01954745) | Massachusetts General Hospital | 2013-09-01 |
| CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery (NCT01766219) | Wake Forest University Health Sciences | 2013-05-01 |
| Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery (NCT01859182) | National Cancer Institute (NCI) | 2013-01-01 |
| Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies (NCT01643499) | University of Chicago | 2012-03-26 |
| Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers (NCT01229111) | National Cancer Institute (NCI) | 2010-10-01 |
| B-Receptor Signaling in Cardiomyopathy (NCT01135849) | Daniel Bernstein | 2008-11-01 |
| Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers (NCT00832637) | New Mexico Cancer Research Alliance | 2007-08-01 |
| Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors (NCT00356889) | National Cancer Institute (NCI) | 2006-05-01 |
| S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma (NCT00238212) | National Cancer Institute (NCI) | 2005-10-01 |
| Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer (NCT00033462) | National Cancer Institute (NCI) | 2002-03-01 |
| BMS-247550 in Treating Patients With Liver or Gallbladder Cancer (NCT00023946) | National Cancer Institute (NCI) | 2001-08-01 |
| Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery (NCT00253617) | Jonsson Comprehensive Cancer Center | |